Table of Content


1 INTRODUCTION 31
1.1 OBJECTIVES OF STUDY 31
1.2 MARKET DEFINITION 31
1.2.1 INCLUSIONS AND EXCLUSIONS 31
1.3 MARKET SCOPE 32
1.3.1 MARKETS COVERED 32
FIGURE 1 GLOBAL BIOMATERIALS MARKET SEGMENTATION 32
1.3.2 YEARS CONSIDERED FOR THE STUDY 33
1.4 CURRENCY 33
1.5 LIMITATIONS 33
1.6 STAKEHOLDERS 33
1.7 SUMMARY OF CHANGES 34

2 RESEARCH METHODOLOGY 35
2.1 RESEARCH DATA 35
FIGURE 2 RESEARCH DESIGN 35
2.1.1 SECONDARY DATA 36
2.1.1.1 Key data from secondary sources 36
2.1.2 PRIMARY DATA 37
FIGURE 3 PRIMARY SOURCES 37
2.1.2.1 Key data from primary sources 38
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS 38
2.2 MARKET SIZE ESTIMATION 39
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 39
FIGURE 6 MARKET SIZE ESTIMATION: BIOMATERIALS MARKET 40
FIGURE 7 SEGMENTAL ASSESSMENT: BIOMATERIALS MARKET 41
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 42
FIGURE 8 DATA TRIANGULATION METHODOLOGY 42
2.4 MARKET SHARE ESTIMATION 43
2.5 ASSUMPTIONS FOR THE STUDY 43

3 EXECUTIVE SUMMARY 44
FIGURE 9 BIOMATERIALS MARKET, BY TYPE, 2020 VS. 2025 (USD BILLION) 44
FIGURE 10 METALLIC BIOMATERIALS MARKET, BY TYPE, 2020 VS. 2025 (USD BILLION) 45
FIGURE 11 CERAMIC BIOMATERIALS MARKET, BY TYPE, 2020 VS. 2025 (USD BILLION) 45
FIGURE 12 POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2020 VS. 2025 (USD BILLION) 46
FIGURE 13 NATURAL BIOMATERIALS MARKET, BY TYPE, 2020 VS. 2025 (USD BILLION) 47
FIGURE 14 CARDIOVASCULAR APPLICATIONS DOMINATED THE BIOMATERIALS MARKET IN 2019 48
FIGURE 15 GEOGRAPHICAL SNAPSHOT OF THE BIOMATERIALS MARKET 49

4 PREMIUM INSIGHTS 50
4.1 BIOMATERIALS MARKET OVERVIEW 50
FIGURE 16 INCREASING DEMAND FOR IMPLANTABLE DEVICES TO DRIVE THE GROWTH OF THE MARKET 50
4.2 NORTH AMERICA: BIOMATERIALS MARKET, BY TYPE & COUNTRY (2019) 51
FIGURE 17 METALLIC BIOMATERIALS TO DOMINATE THE NORTH AMERICAN BIOMATERIALS MARKET IN 2019 51
4.3 METALLIC BIOMATERIALS MARKET, BY TYPE 52
FIGURE 18 TITANIUM & TITANIUM ALLOYS ARE PROJECTED TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD 52

5 MARKET OVERVIEW 53
5.1 INTRODUCTION 53
5.2 MARKET DYNAMICS 53
FIGURE 19 BIOMATERIALS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, CHALLENGES, AND TRENDS 53
5.2.1 DRIVERS 54
5.2.1.1 Increased funds and grants by government bodies and universities for the development of novel biomaterials 54
5.2.1.2 Increasing demand for implantable devices 54
5.2.1.3 Growing demand for biomaterials in plastic surgery and wound healing applications 55
5.2.1.4 Rising incidence of cardiovascular diseases 55
5.2.1.5 Increasing research on regenerative medicine 56
5.2.2 RESTRAINTS 57
5.2.2.1 Stringent clinical & regulatory processes 57
5.2.2.2 Unfavorable healthcare reforms in the US 57
5.2.3 OPPORTUNITIES 57
5.2.3.1 Growing healthcare market in emerging economies 57
5.2.3.2 Increasing number of free-trade agreements 58
5.2.4 CHALLENGES 59
5.2.4.1 Limitations of biomaterial-based products 59
5.2.4.2 Shortage of skilled surgeons 59
5.2.5 TRENDS 59
5.2.5.1 Impact of COVID-19 on the biomaterials market 59
_

6 REGULATORY ASSESSMENT 61
6.1 INTRODUCTION 61
6.2 US 61
6.2.1 INTRODUCTION 61
6.2.2 FDA DEVICE CLASSIFICATION 62
FIGURE 20 US: REGULATORY APPROVAL PROCESS 63
6.2.3 US: REGULATORY APPROVAL TIMELINE ASSESSMENT 64
FIGURE 21 REGULATORY APPROVAL TIMELINE IN THE US 64
6.2.4 STRINGENT FDA REGULATIONS GOVERNING PRODUCT APPROVALS 65
6.3 CANADA 65
6.3.1 INTRODUCTION 65
FIGURE 22 CANADA: REGULATORY APPROVAL PROCESS 66
6.3.2 CANADA: REGULATORY APPROVAL TIMELINE ASSESSMENT 67
FIGURE 23 REGULATORY APPROVAL TIMELINE IN CANADA 67
6.3.3 HEALTH CANADA CLASSIFICATION 67
6.4 EUROPE 68
6.4.1 INTRODUCTION 68
6.4.2 EUROPEAN MEDICAL DEVICE CLASSIFICATION 68
FIGURE 24 EUROPE: REGULATORY APPROVAL PROCESS 69
6.4.3 EUROPE: REGULATORY APPROVAL TIMELINE ASSESSMENT 70
FIGURE 25 REGULATORY APPROVAL TIMELINE IN EUROPE 70
6.4.4 EUROPEAN REGULATORY PROCESS TO GET MORE STRINGENT IN FUTURE 70
6.5 JAPAN 71
6.5.1 INTRODUCTION 71
6.5.2 PMDA DEVICE CLASSIFICATION 71
FIGURE 26 JAPAN: REGULATORY APPROVAL PROCESS 72
6.5.3 JAPAN: REGULATORY APPROVAL TIMELINE ASSESSMENT 73
FIGURE 27 REGULATORY APPROVAL TIMELINE IN JAPAN 73
6.5.4 REVISION OF THE PHARMACEUTICAL AFFAIRS LAW (PAL) AND IMPLEMENTATION OF THE NEW PMD ACT IN JAPAN 73
6.6 CHINA 74
6.6.1 INTRODUCTION 74
6.6.2 CFDA DEVICE CLASSIFICATION 75
FIGURE 28 CHINA: REGULATORY APPROVAL PROCESS 75
6.6.3 CHINA: REGULATORY APPROVAL TIMELINE ASSESSMENT 76
FIGURE 29 REGULATORY APPROVAL TIMELINE IN CHINA 76
6.6.4 RISING HURDLES IN THE REGULATORY PROCESS IN CHINA 76
6.7 INDIA 77
6.7.1 INTRODUCTION 77
FIGURE 30 INDIA: REGULATORY APPROVAL PROCESS 77
6.7.2 INDIAN MEDICAL DEVICES CLASSIFICATION 78
_
6.8 AUSTRALIA 78
6.8.1 INTRODUCTION 78
6.8.2 TGA DEVICE CLASSIFICATION 79
FIGURE 31 AUSTRALIA: REGULATORY APPROVAL PROCESS 80
6.8.3 AUSTRALIA: REGULATORY APPROVAL TIMELINE ASSESSMENT 81
FIGURE 32 REGULATORY APPROVAL TIMELINE IN AUSTRALIA 81

7 BIOMATERIALS MARKET, BY TYPE 82
7.1 INTRODUCTION 83
TABLE 1 IMPORTANT PROPERTIES OF BIOMATERIALS, BY APPLICATION 83
TABLE 2 BIOMATERIALS MARKET, BY TYPE, 2016–2019 (USD MILLION) 83
TABLE 3 BIOMATERIALS MARKET, BY TYPE, 2020–2025 (USD MILLION) 84
7.2 METALLIC BIOMATERIALS 84
TABLE 4 METALLIC BIOMATERIALS MARKET, BY TYPE, 2016–2019 (USD MILLION) 84
TABLE 5 METALLIC BIOMATERIALS MARKET, BY TYPE, 2020–2025 (USD MILLION) 85
TABLE 6 METALLIC BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION) 85
TABLE 7 METALLIC BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION) 85
7.2.1 STAINLESS STEEL 86
7.2.1.1 Stainless steel dominates the metallic biomaterials market 86
TABLE 8 STAINLESS STEEL BIOMATERIALS MARKET, BY REGION,
2016–2019 (USD MILLION) 86
TABLE 9 STAINLESS STEEL BIOMATERIALS MARKET, BY REGION,
2020–2025 (USD MILLION) 86
7.2.2 TITANIUM & TITANIUM ALLOYS 87
7.2.2.1 Growing number of joint replacement procedures will drive the market for titanium biomaterials 87
TABLE 10 TITANIUM & TITANIUM ALLOY BIOMATERIALS MARKET, BY REGION,
2016–2019 (USD MILLION) 87
TABLE 11 TITANIUM & TITANIUM ALLOY BIOMATERIALS MARKET, BY REGION,
2020–2025 (USD MILLION) 87
7.2.3 COBALT-CHROME ALLOYS 88
7.2.3.1 Low cost and excellent corrosion resistance have driven the use of cobalt-chrome alloys 88
TABLE 12 COBALT-CHROME ALLOY BIOMATERIALS MARKET, BY REGION,
2016–2019 (USD MILLION) 88
TABLE 13 COBALT-CHROME ALLOY BIOMATERIALS MARKET, BY REGION,
2020–2025 (USD MILLION) 88
7.2.4 GOLD 89
7.2.4.1 Expanding applications of gold nanoparticles to drive the demand for gold biomaterials 89
TABLE 14 GOLD BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION) 89
TABLE 15 GOLD BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION) 89
7.2.5 SILVER 90
7.2.5.1 Toxic properties and low aesthetic appeal likely to limit the use of silver in biomaterial-based products 90
TABLE 16 SILVER BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION) 90
TABLE 17 SILVER BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION) 90
7.2.6 MAGNESIUM 91
7.2.6.1 Biodegradable characteristic of magnesium stimulates the growth of this market segment 91
TABLE 18 MAGNESIUM BIOMATERIALS MARKET, BY REGION,
2016–2019 (USD MILLION) 91
TABLE 19 MAGNESIUM BIOMATERIALS MARKET, BY REGION,
2020–2025 (USD MILLION) 91
7.3 POLYMERIC BIOMATERIALS 92
TABLE 20 APPLICATIONS OF SYNTHETIC POLYMERS 92
TABLE 21 POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2016–2019 (USD MILLION) 93
TABLE 22 POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2020–2025 (USD MILLION) 93
TABLE 23 POLYMERIC BIOMATERIALS MARKET, BY REGION,
2016–2019 (USD MILLION) 93
TABLE 24 POLYMERIC BIOMATERIALS MARKET, BY REGION,
2020–2025 (USD MILLION) 94
7.3.1 POLYMETHYLMETHACRYLATE (PMMA) 94
7.3.1.1 PMMA dominates the polymeric biomaterials market 94
TABLE 25 POLYMETHYLMETHACRYLATE BIOMATERIALS MARKET, BY REGION,
2016–2019 (USD MILLION) 94
TABLE 26 POLYMETHYLMETHACRYLATE BIOMATERIALS MARKET, BY REGION,
2020–2025 (USD MILLION) 95
7.3.2 POLYETHYLENE 95
7.3.2.1 Wear and tear resistance of polyethylene has made it popular in hip and knee joint replacements 95
TABLE 27 POLYETHYLENE BIOMATERIALS MARKET, BY REGION,
2016–2019 (USD MILLION) 95
TABLE 28 POLYETHYLENE BIOMATERIALS MARKET, BY REGION,
2020–2025 (USD MILLION) 96
7.3.3 POLYESTER 96
7.3.3.1 Biodegradable nature and biocompatibility of polyester will drive its use in various medical applications 96
TABLE 29 POLYESTER BIOMATERIALS MARKET, BY REGION,
2016–2019 (USD MILLION) 96
TABLE 30 POLYESTER BIOMATERIALS MARKET, BY REGION,
2020–2025 (USD MILLION) 97
7.3.4 POLYVINYLCHLORIDE 97
7.3.4.1 Heavy chlorine content of PVC is likely to hamper the market growth 97
TABLE 31 POLYVINYLCHLORIDE BIOMATERIALS MARKET, BY REGION,
2016–2019 (USD MILLION) 97
TABLE 32 POLYVINYLCHLORIDE BIOMATERIALS MARKET, BY REGION,
2020–2025 (USD MILLION) 97
7.3.5 SILICONE RUBBER 98
7.3.5.1 Silicone rubbers are non-reactive, stable, and resistant to extreme environments and temperatures 98
TABLE 33 SILICONE RUBBER BIOMATERIALS MARKET, BY REGION,
2016–2019 (USD MILLION) 98
TABLE 34 SILICONE RUBBER BIOMATERIALS MARKET, BY REGION,
2020–2025 (USD MILLION) 98
7.3.6 NYLON 99
7.3.6.1 Low weight, corrosion resistance, and wide applications of nylon are expected to drive the market demand 99
TABLE 35 NYLON BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION) 99
TABLE 36 NYLON BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION) 99
7.3.7 POLYETHERETHERKETONE 100
7.3.7.1 PEEK is gaining popularity as a viable alternative to metals 100
TABLE 37 POLYETHERETHERKETONE BIOMATERIALS MARKET, BY REGION,
2016–2019 (USD MILLION) 100
TABLE 38 POLYETHERETHERKETONE BIOMATERIALS MARKET, BY REGION,
2020–2025 (USD MILLION) 100
7.3.8 OTHER POLYMERIC BIOMATERIALS 101
TABLE 39 OTHER POLYMERIC BIOMATERIALS MARKET, BY REGION,
2016–2019 (USD MILLION) 101
TABLE 40 OTHER POLYMERIC BIOMATERIALS MARKET, BY REGION,
2020–2025 (USD MILLION) 101
7.4 CERAMIC BIOMATERIALS 102
TABLE 41 CERAMIC BIOMATERIALS MARKET, BY TYPE, 2016–2019 (USD MILLION) 102
TABLE 42 CERAMIC BIOMATERIALS MARKET, BY TYPE, 2020–2025 (USD MILLION) 102
TABLE 43 CERAMIC BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION) 103
TABLE 44 CERAMIC BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION) 103
7.4.1 CALCIUM PHOSPHATE 103
7.4.1.1 Calcium phosphate is the largest segment in the ceramic biomaterials market 103
TABLE 45 CALCIUM PHOSPHATE BIOMATERIALS MARKET, BY REGION,
2016–2019 (USD MILLION) 104
TABLE 46 CALCIUM PHOSPHATE BIOMATERIALS MARKET, BY REGION,
2020–2025 (USD MILLION) 104
7.4.2 ZIRCONIA 104
7.4.2.1 Bio-inertness and low wear rate of zirconia will boost the market growth 104
TABLE 47 ZIRCONIA BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION) 105
TABLE 48 ZIRCONIA BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION) 105
7.4.3 ALUMINUM OXIDE 105
7.4.3.1 Increasing use of aluminum oxide in hip replacements and dental implants to drive the market 105
TABLE 49 ALUMINUM OXIDE BIOMATERIALS MARKET, BY REGION,
2016–2019 (USD MILLION) 105
TABLE 50 ALUMINUM OXIDE BIOMATERIALS MARKET, BY REGION,
2020–2025 (USD MILLION) 106
7.4.4 CALCIUM SULFATE 106
7.4.4.1 Fast resorption rate of calcium sulfate is likely to hamper its use 106
TABLE 51 CALCIUM SULFATE BIOMATERIALS MARKET, BY REGION,
2016–2019 (USD MILLION) 106
TABLE 52 CALCIUM SULFATE BIOMATERIALS MARKET, BY REGION,
2020–2025 (USD MILLION) 107
7.4.5 CARBON 107
7.4.5.1 Increasing use of carbon nanofibers in regenerative medicine and cancer treatment will drive market growth 107
TABLE 53 CARBON BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION) 107
TABLE 54 CARBON BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION) 108
7.4.6 GLASS 108
7.4.6.1 Rising number of orthopedic and dental procedures is likely to drive the demand for glass biomaterials 108
TABLE 55 GLASS BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION) 108
TABLE 56 GLASS BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION) 108
7.5 NATURAL BIOMATERIALS 109
TABLE 57 APPLICATIONS OF NATURAL BIOMATERIALS 109
TABLE 58 NATURAL BIOMATERIALS MARKET, BY TYPE, 2016–2019 (USD MILLION) 110
TABLE 59 NATURAL BIOMATERIALS MARKET, BY TYPE, 2020–2025 (USD MILLION) 110
TABLE 60 NATURAL BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION) 110
TABLE 61 NATURAL BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION) 111
7.5.1 HYALURONIC ACID 111
7.5.1.1 Rising prevalence of osteoarthritis to drive the hyaluronic acid market 111
TABLE 62 HYALURONIC ACID BIOMATERIALS MARKET, BY REGION,
2016–2019 (USD MILLION) 111
TABLE 63 HYALURONIC ACID BIOMATERIALS MARKET, BY REGION,
2020–2025 (USD MILLION) 111
7.5.2 COLLAGEN 112
7.5.2.1 Rising prevalence of target applications to drive growth in the collagen market 112
TABLE 64 COLLAGEN BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION) 112
TABLE 65 COLLAGEN BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION) 112
7.5.3 GELATIN 113
7.5.3.1 Low cost of gelatin to drive its market growth 113
TABLE 66 GELATIN BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION) 113
TABLE 67 GELATIN BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION) 113
7.5.4 FIBRIN 114
7.5.4.1 Fibrin biomaterials were among the first used to prevent bleeding 114
TABLE 68 FIBRIN BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION) 114
TABLE 69 FIBRIN BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION) 114
7.5.5 CELLULOSE 115
7.5.5.1 Cellulose finds applications in wound healing, skin regeneration,
and ophthalmology 115
TABLE 70 CELLULOSE BIOMATERIALS MARKET, BY REGION,
2016–2019 (USD MILLION) 115
TABLE 71 CELLULOSE BIOMATERIALS MARKET, BY REGION,
2020–2025 (USD MILLION) 115
7.5.6 CHITIN 116
7.5.6.1 Chitin accelerates skin regeneration and possesses high biocompatibility 116
TABLE 72 CHITIN BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION) 116
TABLE 73 CHITIN BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION) 116
7.5.7 ALGINATES 117
7.5.7.1 Various applications of alginates include wound healing, tissue engineering & regenerative medicine, and drug delivery 117
TABLE 74 ALGINATE BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION) 117
TABLE 75 ALGINATE BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION) 117
7.5.8 SILK 118
7.5.8.1 Flexibility, glossiness, and adhesive abilities of silk have made it popular in cosmetic applications 118
TABLE 76 SILK BIOMATERIALS MARKET, BY REGION, 2016–2019 (USD MILLION) 118
TABLE 77 SILK BIOMATERIALS MARKET, BY REGION, 2020–2025 (USD MILLION) 118

8 BIOMATERIALS MARKET, BY APPLICATION 119
8.1 INTRODUCTION 120
TABLE 78 BIOMATERIALS MARKET, BY APPLICATION, 2016–2019 (USD MILLION) 120
TABLE 79 BIOMATERIALS MARKET, BY APPLICATION, 2020–2025 (USD MILLION) 120
8.2 CARDIOVASCULAR 121
TABLE 80 BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS,
BY PRODUCT, 2016–2019 (USD MILLION) 121
TABLE 81 BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS,
BY PRODUCT, 2020–2025 (USD MILLION) 122
TABLE 82 BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY REGION, 2016–2019 (USD MILLION) 122
TABLE 83 BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY REGION, 2020–2025 (USD MILLION) 122
8.2.1 CATHETERS 123
8.2.1.1 Shift in patient preference from traditional open surgeries to minimally invasive surgeries to drive the catheters market 123
TABLE 84 BIOMATERIALS MARKET FOR CATHETERS, BY REGION,
2016–2019 (USD MILLION) 123
TABLE 85 BIOMATERIALS MARKET FOR CATHETERS, BY REGION,
2020–2025 (USD MILLION) 123
8.2.2 STENTS 124
8.2.2.1 Increasing number of coronary intervention procedures to boost the demand for implantable stents 124
TABLE 86 BIOMATERIALS MARKET FOR STENTS, BY REGION,
2016–2019 (USD MILLION) 124
TABLE 87 BIOMATERIALS MARKET FOR STENTS, BY REGION,
2020–2025 (USD MILLION) 124
8.2.3 IMPLANTABLE CARDIAC DEFIBRILLATORS 125
8.2.3.1 Growing geriatric population is expected to increase the demand for implantable cardiac defibrillators 125
TABLE 88 BIOMATERIALS MARKET FOR IMPLANTABLE CARDIAC DEFIBRILLATORS,
BY REGION, 2016–2019 (USD MILLION) 125
TABLE 89 BIOMATERIALS MARKET FOR IMPLANTABLE CARDIAC DEFIBRILLATORS,
BY REGION, 2020–2025 (USD MILLION) 125
8.2.4 PACEMAKERS 126
8.2.4.1 High prevalence of bradycardia is increasing the demand for pacemakers 126
TABLE 90 BIOMATERIALS MARKET FOR PACEMAKERS, BY REGION,
2016–2019 (USD MILLION) 126
TABLE 91 BIOMATERIALS MARKET FOR PACEMAKERS, BY REGION,
2020–2025 (USD MILLION) 126
8.2.5 SENSORS 127
8.2.5.1 Increasing prevalence of cardiac disorders is boosting the demand for cardiovascular sensors 127
TABLE 92 BIOMATERIALS MARKET FOR SENSORS, BY REGION,
2016–2019 (USD MILLION) 127
TABLE 93 BIOMATERIALS MARKET FOR SENSORS, BY REGION,
2020–2025 (USD MILLION) 127
8.2.6 HEART VALVES 128
8.2.6.1 Growing geriatric population is set to increase the demand for prosthetic valves 128
TABLE 94 BIOMATERIALS USED FOR DIFFERENT VALVE COMPONENTS 128
TABLE 95 BIOMATERIALS MARKET FOR HEART VALVES, BY REGION,
2016–2019 (USD MILLION) 128
TABLE 96 BIOMATERIALS MARKET FOR HEART VALVES, BY REGION,
2020–2025 (USD MILLION) 129
8.2.7 VASCULAR GRAFTS 129
8.2.7.1 Various research studies related to the use of biomaterials in vascular grafts will open opportunities for growth of the market 129
TABLE 97 BIOMATERIALS MARKET FOR VASCULAR GRAFTS, BY REGION,
2016–2019 (USD MILLION) 129
TABLE 98 BIOMATERIALS MARKET FOR VASCULAR GRAFTS, BY REGION,
2020–2025 (USD MILLION) 130
8.2.8 GUIDEWIRES 130
8.2.8.1 Guidewires are widely used for guiding catheters and placing stents inside the heart 130
TABLE 99 BIOMATERIALS MARKET FOR GUIDEWIRES, BY REGION,
2016–2019 (USD MILLION) 130
TABLE 100 BIOMATERIALS MARKET FOR GUIDEWIRES, BY REGION,
2020–2025 (USD MILLION) 130
8.2.9 OTHER PRODUCTS 131
TABLE 101 BIOMATERIALS MARKET FOR OTHER PRODUCTS, BY REGION,
2016–2019 (USD MILLION) 131
TABLE 102 BIOMATERIALS MARKET FOR OTHER PRODUCTS, BY REGION,
2020–2025 (USD MILLION) 131
_
8.3 ORTHOPEDIC 132
TABLE 103 BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE,
2016–2019 (USD MILLION) 132
TABLE 104 BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE,
2020–2025 (USD MILLION) 133
TABLE 105 BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY REGION, 2016–2019 (USD MILLION) 133
TABLE 106 BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY REGION, 2020–2025 (USD MILLION) 133
8.3.1 JOINT REPLACEMENT 134
TABLE 107 JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE,
2016–2019 (USD MILLION) 134
TABLE 108 JOINT REPLACEMENT BIOMATERIALS MARKET, BY TYPE,
2020–2025 (USD MILLION) 134
TABLE 109 JOINT REPLACEMENT BIOMATERIALS MARKET, BY REGION,
2016–2019 (USD MILLION) 135
TABLE 110 JOINT REPLACEMENT BIOMATERIALS MARKET, BY REGION,
2020–2025 (USD MILLION) 135
8.3.1.1 Knee replacement 136
8.3.1.1.1 Increasing number of knee replacement procedures across the globe to drive market growth 136
TABLE 111 KNEE REPLACEMENT BIOMATERIALS MARKET, BY REGION,
2016–2019 (USD MILLION) 136
TABLE 112 KNEE REPLACEMENT BIOMATERIALS MARKET, BY REGION,
2020–2025 (USD MILLION) 136
8.3.1.2 Hip replacement 137
8.3.1.2.1 Hip and knee joint replacements are the most commonly performed procedures in the US?a key factor driving growth 137
TABLE 113 HIP REPLACEMENT BIOMATERIALS MARKET, BY REGION,
2016–2019 (USD MILLION) 137
TABLE 114 HIP REPLACEMENT BIOMATERIALS MARKET, BY REGION,
2020–2025 (USD MILLION) 137
8.3.1.3 Shoulder replacement 138
8.3.1.3.1 Shoulder replacement is the most common joint replacement surgery conducted globally 138
TABLE 115 SHOULDER REPLACEMENT BIOMATERIALS MARKET, BY REGION,
2016–2019 (USD MILLION) 138
TABLE 116 SHOULDER REPLACEMENT BIOMATERIALS MARKET, BY REGION,
2020–2025 (USD MILLION) 138
8.3.1.4 Other joint replacement applications 139
TABLE 117 OTHER JOINT REPLACEMENT BIOMATERIALS MARKET, BY REGION,
2016–2019 (USD MILLION) 139
TABLE 118 OTHER JOINT REPLACEMENT BIOMATERIALS MARKET, BY REGION,
2020–2025 (USD MILLION) 139
8.3.2 VISCOSUPPLEMENTATION 140
8.3.2.1 Rising cases of osteoarthritis will drive growth in the viscosupplementation market 140
TABLE 119 VISCOSUPPLEMENTATION BIOMATERIALS MARKET, BY REGION,
2016–2019 (USD MILLION) 140
TABLE 120 VISCOSUPPLEMENTATION BIOMATERIALS MARKET, BY REGION,
2020–2025 (USD MILLION) 141
8.3.3 BIORESORBABLE TISSUE FIXATION 141
TABLE 121 BIORESORBABLE BIOMATERIALS MARKET, BY PRODUCT,
2016–2019 (USD MILLION) 141
TABLE 122 BIORESORBABLE BIOMATERIALS MARKET, BY PRODUCT,
2020–2025 (USD MILLION) 142
TABLE 123 BIORESORBABLE BIOMATERIALS MARKET, BY REGION,
2016–2019 (USD MILLION) 142
TABLE 124 BIORESORBABLE BIOMATERIALS MARKET, BY REGION,
2020–2025 (USD MILLION) 142
8.3.3.1 Suture anchors 143
8.3.3.1.1 Growing awareness about suture anchor devices will drive market growth 143
TABLE 125 BIOMATERIALS MARKET FOR SUTURE ANCHORS, BY REGION,
2016–2019 (USD MILLION) 143
TABLE 126 BIOMATERIALS MARKET FOR SUTURE ANCHORS, BY REGION,
2020–2025 (USD MILLION) 143
8.3.3.2 Interference screws 144
8.3.3.2.1 Increasing awareness about ACL will contribute to market growth 144
TABLE 127 BIOMATERIALS MARKET FOR INTERFERENCE SCREWS, BY REGION,
2016–2019 (USD MILLION) 144
TABLE 128 BIOMATERIALS MARKET FOR INTERFERENCE SCREWS, BY REGION,
2020–2025 (USD MILLION) 144
8.3.3.3 Meniscal repair tacks 145
8.3.3.3.1 Rising sports injuries will drive growth in the meniscal repair tacks market 145
TABLE 129 BIOMATERIALS MARKET FOR MENISCAL REPAIR TACKS, BY REGION,
2016–2019 (USD MILLION) 145
TABLE 130 BIOMATERIALS MARKET FOR MENISCAL REPAIR TACKS, BY REGION,
2020–2025 (USD MILLION) 145
8.3.3.4 Meshes 146
8.3.3.4.1 Wear resistance, proper shaping, and holding capacity of bioresorbable implants increase the demand for bioresorbable meshes 146
TABLE 131 BIOMATERIALS MARKET FOR MESHES, BY REGION,
2016–2019 (USD MILLION) 146
TABLE 132 BIOMATERIALS MARKET FOR MESHES, BY REGION,
2020–2025 (USD MILLION) 146
8.3.4 SPINE 147
TABLE 133 BIOMATERIALS MARKET FOR SPINE SURGERIES, BY TYPE,
2016–2019 (USD MILLION) 147
TABLE 134 BIOMATERIALS MARKET FOR SPINE SURGERIES, BY TYPE,
2020–2025 (USD MILLION) 147
TABLE 135 BIOMATERIALS MARKET FOR SPINE SURGERIES, BY REGION,
2016–2019 (USD MILLION) 147
TABLE 136 BIOMATERIALS MARKET FOR SPINE SURGERIES, BY REGION,
2020–2025 (USD MILLION) 148
8.3.4.1 Spinal fusion 148
8.3.4.1.1 Introduction of minimally invasive spinal fusion procedures and better clinical outcomes to drive market growth 148
TABLE 137 BIOMATERIALS MARKET FOR SPINAL FUSION SURGERIES, BY REGION, 2016–2019 (USD MILLION) 148
TABLE 138 BIOMATERIALS MARKET FOR SPINAL FUSION SURGERIES, BY REGION, 2020–2025 (USD MILLION) 149
8.3.4.2 Minimally invasive fusion 149
8.3.4.2.1 Advantages such as lesser pain post surgery and faster recovery to drive the demand for minimally invasive fusion procedures 149
TABLE 139 BIOMATERIALS MARKET FOR MINIMALLY INVASIVE FUSION SURGERIES,
BY REGION, 2016–2019 (USD MILLION) 149
TABLE 140 BIOMATERIALS MARKET FOR MINIMALLY INVASIVE FUSION SURGERIES,
BY REGION, 2020–2025 (USD MILLION) 150
8.3.4.3 Motion preservation & dynamic stabilization 150
TABLE 141 BIOMATERIALS MARKET FOR MOTION PRESERVATION & DYNAMIC STABILIZATION SURGERIES, BY PRODUCT, 2016–2019 (USD MILLION) 150
TABLE 142 BIOMATERIALS MARKET FOR MOTION PRESERVATION & DYNAMIC STABILIZATION SURGERIES, BY PRODUCT, 2020–2025 (USD MILLION) 151
TABLE 143 BIOMATERIALS MARKET FOR MOTION PRESERVATION & DYNAMIC STABILIZATION SURGERIES, BY REGION, 2016–2019 (USD MILLION) 151
TABLE 144 BIOMATERIALS MARKET FOR MOTION PRESERVATION & DYNAMIC STABILIZATION SURGERIES, BY REGION, 2020–2025 (USD MILLION) 151
8.3.4.3.1 Pedicle-based rod systems 152
8.3.4.3.1.1 Rising geriatric population will result in growth in the pedicle-based rod systems market 152
TABLE 145 BIOMATERIALS MARKET FOR PEDICLE-BASED ROD SYSTEMS, BY REGION, 2016–2019 (USD MILLION) 152
TABLE 146 BIOMATERIALS MARKET FOR PEDICLE-BASED ROD SYSTEMS, BY REGION, 2020–2025 (USD MILLION) 152
8.3.4.3.2 Interspinous spacers 153
8.3.4.3.2.1 High prevalence of degenerative spinal conditions will contribute to the growth of the interspinous spacers market 153
TABLE 147 BIOMATERIALS MARKET FOR INTERSPINOUS SPACERS, BY REGION,
2016–2019 (USD MILLION) 153
TABLE 148 BIOMATERIALS MARKET FOR INTERSPINOUS SPACERS, BY REGION,
2020–2025 (USD MILLION) 153
8.3.4.3.3 Artificial discs 154
8.3.4.3.3.1 High biocompatibility of biomaterials has led to their increased use in artificial discs 154
TABLE 149 BIOMATERIALS MARKET FOR ARTIFICIAL DISCS, BY REGION,
2016–2019 (USD MILLION) 154
TABLE 150 BIOMATERIALS MARKET FOR ARTIFICIAL DISCS, BY REGION,
2020–2025 (USD MILLION) 154
8.3.5 FRACTURE FIXATION DEVICES 155
TABLE 151 BIOMATERIALS MARKET FOR FRACTURE FIXATION DEVICES, BY TYPE,
2016–2019 (USD MILLION) 155
TABLE 152 BIOMATERIALS MARKET FOR FRACTURE FIXATION DEVICES, BY TYPE,
2020–2025 (USD MILLION) 155
TABLE 153 BIOMATERIALS MARKET FOR FRACTURE FIXATION DEVICES, BY REGION, 2016–2019 (USD MILLION) 156
TABLE 154 BIOMATERIALS MARKET FOR FRACTURE FIXATION DEVICES, BY REGION, 2020–2025 (USD MILLION) 156
8.3.5.1 Bone plates 157
8.3.5.1.1 Biomaterials form an integral component of bone plates due to their high biocompatibility 157
TABLE 155 BIOMATERIALS MARKET FOR BONE PLATES, BY REGION,
2016–2019 (USD MILLION) 157
TABLE 156 BIOMATERIALS MARKET FOR BONE PLATES, BY REGION,
2020–2025 (USD MILLION) 157
8.3.5.2 Screws 158
8.3.5.2.1 Screws made up of biomaterials such as stainless steel, titanium, and cobalt are extensively used in orthopedic procedures 158
TABLE 157 BIOMATERIALS MARKET FOR SCREWS, BY REGION,
2016–2019 (USD MILLION) 158
TABLE 158 BIOMATERIALS MARKET FOR SCREWS, BY REGION,
2020–2025 (USD MILLION) 158
8.3.5.3 Pins 159
8.3.5.3.1 Nonreactive metallic biomaterials such as stainless steel, titanium, and cobalt are majorly used to manufacture pins 159
TABLE 159 BIOMATERIALS MARKET FOR PINS, BY REGION, 2016–2019 (USD MILLION) 159
TABLE 160 BIOMATERIALS MARKET FOR PINS, BY REGION, 2020–2025 (USD MILLION) 159
8.3.5.4 Rods 160
8.3.5.4.1 Rods are preferred for fracture fixation procedures due to their high rigidity, easy mobility, and cost effic